StockData
HeartBeam, Inc. logo

HeartBeam, Inc. (BEAT) company profile

BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.34+0.01 (+1.98%)

Close on Nov 18, 2026Market cap $19.18MP/E –Yield –

About HeartBeam

Surgical & Medical Instruments & Apparatus, SIC 3841

HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions designed for use outside clinical environments. The company's primary offering is the HeartBeam System, a cable-free cardiac monitoring platform comprising a credit-card-sized three-dimensional electrocardiogram (ECG) recording device, a patient mobile application, cloud-based algorithms, and a web-based physician portal. The system records electrical signals from the heart across three dimensions to synthesize twelve-lead ECG readings for remote arrhythmia assessment, supported by continuous access to on-demand cardiologists. Target customers include concierge physicians, preventive cardiology practices, and hospital cardiology departments.

The company operates primarily within the United States, targeting initial commercialization through select cardiology practices and direct sales channels, while exploring potential international expansion opportunities. HeartBeam employed 16 personnel as of late 2025, expanding to 17 staff members in early 2026. The provided text does not disclose the company's specific headquarters location.

Summary of the business section of HeartBeam's latest annual report, written by StockData.

Company profile

Company

Legal name
HeartBeam, Inc.
Headquarters
Santa Clara, CA
Address
2118 Walsh Ave., Suite 210 95050
Phone
(408) 899-4443
Employees
16, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Marcum LLP, Morristown, New Jersey

Stock & identifiers

Ticker
BEAT
Other tickers
BEATW
Exchange
Nasdaq
IPO date
Nov 11, 2021
Shares outstanding
56M, Aug 11, 2026
Public float
$36.37M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1779372
CUSIP
42238H108
ISIN
US42238H1086
FIGI
BBG012F6HZX2
Share class FIGI
BBG012F6HZY1
EIN
47-4881450

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Branislav VajdicPresident, Director3,970,784
Kenneth Harry PersenChief Technology Officer448,290
Tim CruickshankCFO239,990
Robert Paul ENOPresident36,742
Urioste George deDirector0
Kenneth Warwick Nelson IIIDirector144,388
Michael R. JaffDirector127,059
Richard FerrariDirector352,289
Marga Ortigas-WedekindDirector154,117
Willem ElfrinkDirector645,492
Mark E. StromeDirector3,707,146

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOption awardsOtherTotalvs. prior year
Robert Eno
Chief Executive Officer (Former President)
$360.00K$128.52K$40.00K$451.69K$1.03K$1.04M+111%
Branislav Vajdic
President (Former Chief Executive Officer)
$404.10K$144.26K–$330.88K$4.94K$946.01K+51%
Kenneth Persen
Chief System Deployment Officer
$312.00K$58.48K–$28.23K$3.05K$426.82K+15%
Timothy Cruickshank
Chief Financial Officer
$346.50K$92.78K$38.50K$211.73K$238$729.51K-25%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 16 employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?